摘要
阳性手术切缘显著降低可手术非小细胞肺癌患者的生存,然而目前切缘阳性非小细胞肺癌患者的术后辅助治疗模式尚缺乏高级别证据支持。本文综述切缘阳性非小细胞肺癌患者辅助治疗的现状及值得商榷的问题。
For non-small cell lung cancer(NSCLC)patients with positive surgical margins,the survival rates can be dramatically decreased.However,high-level evidence is lacking in the standard adjuvant treatment for NSCLC patients with positive surgical margins.In this article,consensus and disputes on the adjuvant therapy for NSCLC patients with positive surgical margins were reviewed.
作者
袁梦
门玉
康静静
孙鑫
赵茂媛
杨旭
包永兴
惠周光
Yuan Meng;Men Yu;Kang Jingjing;Sun Xin;Zhao Maoyuan;Yang Xu;Bao Yongxing;Hui Zhouguang(Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of VIP Medical Services,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China)
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2020年第10期904-908,共5页
Chinese Journal of Radiation Oncology
关键词
癌
非小细胞肺/切缘阳性
癌
非小细胞肺/术后辅助疗法
现状与争议
Carcinoma,non-small cell lung/positive surgical margin
Carcinoma,non-small cell lung/postoperative adjuvant therapy
Consensus and dispute
